TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-09-10
著者
-
Watanabe Toshiki
Laboratory Of Tumor Cell Biology Department Of Medical Genome Sciences Graduate School Of Frontier S
-
Fujita Naoya
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
KURATA Atsuo
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
KATAYAMA Ryohei
Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Re
-
TSURUO Takashi
Director's Room, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Tsuruo Takashi
Division Of Molecular Oncology Aichi Cancer Center Research Institute
-
Tsuruo Takashi
The Cancer Chemotherapy Center Japanese Foundation For Cancer Research (jfcr)
-
Tsuruo Takashi
Director's Room Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Watanabe Toshiki
Laboratory Of Tumor Cell Biology Department Of Medical Genome Science Graduate School Of Frontier Sc
-
Watanabe Toshiki
Laboratory Of Tumor Cell Biology Department Of Medical Genome Sciences Graduate School Of Frontier S
-
Kurata Atsuo
Division Of Experimental Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Rese
-
KATAYAMA Ryohei
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
-
Tsuruo T
Director's Room Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Katayama Ryohei
Cancer Chemotherapy Center Japanese Foundation For Cancer Research
-
Taniguchi Tetsuo
The Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR)
関連論文
- Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer
- Decreased Synthesis of Matrix Metalloproteinase-7 and Adhesion to the Extracellular Matrix Proteins of Human Colon Cancer Cells Treated with Troglitazone
- Catechin, green tea component, causes caspase-independent necrosis-like cell death in chronic myelogenous leukemia
- TUSC4/NPRL2, a novel PDK1-interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling
- Involvement of mitochondrial aggregation in arsenic trioxide (As_2O_3)-induced apoptosis in human glioblastoma cells
- MOLECULAR TARGETING THERAPY OF CANCER : DRUG RESISTANCE, APOPTOSIS AND SURVIVAL SIGNAL
- Molecular targeting therapy of cancer : drug resistance, apoptosis and survival signal
- Mitochondria regulate the unfolded protein response leading to cancer cell survival under glucose deprivation conditions
- Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin
- Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia/lymphoma
- Expressions of Cell Cycle Regulators in Human Colorectal Cancer Cell Lines
- Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages
- Platelet aggregation in the formation of tumor metastasis
- Isolation of a cDNA Encoding a Chitinase Family Protein from Cuticular Tissues of the Kuruma Prawn Penaeus japonicus
- A New Quinoline Derivative MS-209 Reverses Multidrug Resistance and Inhibits Multiorgan Metastases by P-glycoprotein-expressing Human Small Cell Lung Cancer Cells
- POTENTIATION OF CHEMOTHERAPEUTIC EFFECT OF VINCRISTINE IN VINCRISTINE RESISTANT TUMOR BEARING MICE BY CALMODULIN INHIBITOR CLOMIPRAMINE
- ANTITUMOR EFFICACIES OF ACLACINOMYCIN A BY ORAL ADMINISTRATION
- Structure-antitumor Activity Relationship of Semi-synthetic Spicamycin Derivatives
- Synthesis and Antitumor Activities of Glycine-exchanged Analogs of Spicamycin
- Lysophosphatidic acid stimulates the proliferation and motility of malignant pleural mesothelioma cells through lysophosphatidic acid receptors, LPA1 and LPA2
- Combination Therapy with Antibody and Interleukin-2 Gene Transfer against Multidrug-resistant Cancer Cells
- Transduction of the Macrophage Colony-stimulating Factor Gene into Human Multidrug Resistant Cancer Cells : Enhanced Therapeutic Efficacy of Monoclonal Anti-P-glycoprotein Antibody in Nude Mice
- Vaccination with autologous endothelium inhibits angiogenesis and metastasis of colon cancer through autoimmunity
- Molecular Cloning of a Molt-Inhibiting Hormone cDNA from the Kuruma Prawn Penaeus japonicus
- Immunological Quantitation of DT-Diaphorase in Carcinoma Cell Lines and Clinical Colon Cancers : Advanced Tumors Express Greater Levels of DT-Diaphorase
- Acute Induction of Adriamycin-resistance in Human Colon Carcinoma HT-29 Cells Exposed to a Sublethal Dose of Adriamycin
- Elevation of the activities of β-N-acetylhexosaminidase isozymes by 20-hydroxyecdysone administration in the kuruma prawn
- Inhibition of Tumor Cell Invasion and Matrix Degradation by Aminopeptidase Inhibitors
- A NOVEL ANTITUMOR CYCLIC HEXAPEPTIDE (RA-700) OBTAINED FROM RUBIAE RADIX
- Inhibitory Effect of ATF3 Antisense Oligonucleotide on Ectopic Growth of HT29 Human Colon Cancer Cells
- Analysis of Novel Metastasis-associated Gene TI-227
- Evaluation of Antivascular and Antimitotic Effects Tubulin Binding Agents in Solid Tumor Therapy
- A Novel Combretastatin A-4 Derivative, AC-7700, Shows Marked Antitumor Activity against Advanced Solid Tumors and Orthotopically Transplanted Tumors
- Inhibitory effects of n-3 polyunsaturated fatty acids on sigmoid colon cancer transformants
- Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export
- Acyl-CoA synthetase as a cancer survival factor : its inhibition enhances the efficacy of etoposide
- Hodgkin's Lymphoma and CD30 Signal Transduction
- A novel domain in the CD30 cytoplasmic tail mediates NFkB activation
- Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
- Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
- Inhibition of the Association with Nuclear Matrix of pRB, p70 and p40 Proteins Along with the Specific Suppression of c-MYC Expression by Geldanamycin, an Inhibitor of Sre Tyrosine Kinase
- The side population, as a precursor of Hodgkin and Reed-Sternberg cells and a target for nuclear factor-κB inhibitors in Hodgkin's lymphoma
- Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies